Page 7 - Read Online
P. 7

27         Adenosine A2B receptor: novel anti-cancer therapeutic implications
                            Silvia Paola Corona, Navid Sobhani, Daniele Generali
                            J Cancer Metastasis Treat 2017;3:206-208  http://dx.doi.org/10.20517/2394-4722.2017.50


               28         Health-related quality of life and its correlates among rectal cancer survivors, Northwest of Iran
                            Nayyereh Aminisani, Mehdi Fatemi, Parvin Sarbakhsh, Alireza Nikanfar, Amirtaher Eftekharsadat,
                            Esmat Jafari
                            J Cancer Metastasis Treat 2017;3:209-216  http://dx.doi.org/10.20517/2394-4722.2017.47


               29         Introduction to the Special Issue on Cancer Immunotherapy
                            Shuen-Kuei Liao
                            J Cancer Metastasis Treat 2017;3:217  http://dx.doi.org/10.20517/2394-4722.2017.21

               30         Cancer immunity and therapy using hyperthermia with immunotherapy, radiotherapy,
                            chemotherapy, and surgery
                            Yohsuke Yagawa, Keishi Tanigawa, Yasunobu Kobayashi, Masakazu Yamamoto
                            J Cancer Metastasis Treat 2017;3:218-230  http://dx.doi.org/10.20517/2394-4722.2017.35


               31         Immunological aspect of the liver and metastatic uveal melanoma
                            Mizue Terai, Michael J. Mastrangleo, Takami Sato
                            J Cancer Metastasis Treat 2017;3:231-243  http://dx.doi.org/10.20517/2394-4722.2017.39

               32         Cell-mediated immunotherapy for hepatocellular carcinoma
                            Wei-Chen Lee
                            J Cancer Metastasis Treat 2017;3:244-249  http://dx.doi.org/10.20517/2394-4722.2017.48


               33         Cancer immunotherapy: a brief review of the history, possibilities, and challenges ahead
                            Stanley J. Oiseth, Mohamed S. Aziz
                            J Cancer Metastasis Treat 2017;3:250-261  http://dx.doi.org/10.20517/2394-4722.2017.41


               34         Getting closer to prostate cancer in patients - what scientists should want from clinicians
                            Norman J. Maitland
                            J Cancer Metastasis Treat 2017;3:262-270  http://dx.doi.org/10.20517/2394-4722.2017.23

               35         Getting better at treating prostate cancer: what clinicians should want from scientists
                            Malcolm Mason
                            J Cancer Metastasis Treat 2017;3:271-277  http://dx.doi.org/10.20517/2394-4722.2017.51


               36         HOX transcription factors and the prostate tumor microenvironment
                            Richard Morgan, Hardev S. Pandha
                            J Cancer Metastasis Treat 2017;3:278-287  http://dx.doi.org/10.20517/2394-4722.2017.31

               37         Prostate cancer exosomes as modulators of the tumor microenvironment
                            Alex P. Shephard, Vincent Yeung, Aled Clayton, Jason P. Webber
                            J Cancer Metastasis Treat 2017;3:288-301  http://dx.doi.org/10.20517/2394-4722.2017.32
   2   3   4   5   6   7   8   9   10   11   12